Kruidvat Allergieoogdruppels (Sodium Cromoglicate)

Sodium cromoglicate works by binding to the membranes of mast cells in the conjunctiva and cornea, inhibiting calcium‑dependent degranulation. This blocks the release of histamine, prostaglandins, leukotrienes and other mediators that trigger the allergic cascade, thereby reducing ocular inflammation and discomfort.

The appropriate dosing regimen for Kruidvat Allergieoogdruppels is set by the prescribing eye‑care professional based on the severity of the allergy, patient age and response to therapy. No fixed dosage is provided here; patients should follow the specific instructions given by their clinician.

Safety data for sodium cromoglicate in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To place an enquiry, visit the product page on gnhindia.com, enter the required quantity and submit the request. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike antihistamine eye drops that block histamine receptors, sodium cromoglicate acts upstream by stabilising mast cells, offering a preventive approach. Corticosteroid drops are more potent but carry higher risks of intra‑ocular pressure rise and cataract formation. Sodium cromoglicate provides a favourable safety profile for long‑term use in mild‑to‑moderate allergic eye disease.

Store the eye‑drop bottles at room temperature, away from direct sunlight and moisture. Keep them in the original packaging to protect the sterility of the solution. Do not freeze the product, and discard any bottle that appears discoloured or contaminated.

Instil the prescribed number of drops into each affected eye, typically one drop per eye, using the dropper tip without touching the ocular surface. Close the eye gently for a few seconds to allow distribution, and avoid blinking excessively immediately after application.

Although rare, serious adverse events can include severe allergic reactions such as anaphylaxis, acute keratitis or corneal edema, and sudden loss of visual acuity. If any of these symptoms occur, discontinue use immediately and seek urgent medical attention.

Individuals with a known hypersensitivity to sodium cromoglicate or any excipients in the formulation should avoid this product. Patients with active ocular infections or severe eye trauma should consult an eye‑care professional before use, as the drops may not be appropriate in those conditions.